Several recent studies have identified abnormal expression of H19 in various human cancers, such as colorectal (Wu et al. 2017), liver (Tsang and Kwok 2007), gastric (Ishii et al. 2017), pancreatic (Yoshimura et al. 2018), esophageal (Li et al. 2019), breast (Zhu et al. 2017), lung (Li et al. 2019), glioma (Jia et al. 2018), ovarian (Wu et al. 2019), and hematological cancers (Yang et al. 2020). This evidence concerns the gene H19 and cancer.